JP2010509240A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509240A5
JP2010509240A5 JP2009535499A JP2009535499A JP2010509240A5 JP 2010509240 A5 JP2010509240 A5 JP 2010509240A5 JP 2009535499 A JP2009535499 A JP 2009535499A JP 2009535499 A JP2009535499 A JP 2009535499A JP 2010509240 A5 JP2010509240 A5 JP 2010509240A5
Authority
JP
Japan
Prior art keywords
composition
formula
alkyl
compound
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509240A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/083695 external-priority patent/WO2008058098A2/en
Publication of JP2010509240A publication Critical patent/JP2010509240A/ja
Publication of JP2010509240A5 publication Critical patent/JP2010509240A5/ja
Pending legal-status Critical Current

Links

JP2009535499A 2006-11-07 2007-11-06 喘息、アレルギー性鼻炎および皮膚障害の治療方法 Pending JP2010509240A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85733906P 2006-11-07 2006-11-07
PCT/US2007/083695 WO2008058098A2 (en) 2006-11-07 2007-11-06 Method of treating asthma, allergic rhinitis, and skin disorders

Publications (2)

Publication Number Publication Date
JP2010509240A JP2010509240A (ja) 2010-03-25
JP2010509240A5 true JP2010509240A5 (cg-RX-API-DMAC7.html) 2011-10-20

Family

ID=39276163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535499A Pending JP2010509240A (ja) 2006-11-07 2007-11-06 喘息、アレルギー性鼻炎および皮膚障害の治療方法

Country Status (12)

Country Link
US (2) US20080108695A1 (cg-RX-API-DMAC7.html)
EP (1) EP2079459A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010509240A (cg-RX-API-DMAC7.html)
KR (1) KR20090086573A (cg-RX-API-DMAC7.html)
CN (1) CN101534806A (cg-RX-API-DMAC7.html)
AU (1) AU2007316482A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0718540A2 (cg-RX-API-DMAC7.html)
CA (1) CA2668645A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009004962A (cg-RX-API-DMAC7.html)
TW (1) TW200829232A (cg-RX-API-DMAC7.html)
WO (1) WO2008058098A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200902909B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687539B1 (en) * 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
CA2788333A1 (en) * 2010-02-25 2011-09-01 Alcon Research, Ltd. Method of accelerating corneal wound healing
CN110840878B (zh) * 2019-11-05 2020-06-26 牡丹江医学院 一种用于治疗银屑病的化合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
FR2701477B1 (fr) * 1993-02-16 1995-03-31 Adir Nouveaux composés (cyclohexyl)alcéniques, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
EP1657233A1 (en) * 1993-06-15 2006-05-17 The Brigham & Women's Hospital, Inc. Lipoxin compounds
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
SE9601677D0 (sv) * 1996-05-02 1996-05-02 Scotia Lipidteknik Ab New use
US6831186B2 (en) * 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs
US8815950B2 (en) * 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
US20050203184A1 (en) * 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
DE602005020178D1 (de) * 2004-11-09 2010-05-06 Alcon Inc 5,6,7-trihydroxyheptansäure und analoge zur behandlung von augenkrankheiten und mit hyperproliferativen und angiogenen reaktionen verbundenen krankheiten

Similar Documents

Publication Publication Date Title
RU2013121788A (ru) Ингибиторы репликации вич
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
JP2008543854A5 (cg-RX-API-DMAC7.html)
JP6462045B2 (ja) スルフォラファンの単離及び精製
JP2013519653A5 (cg-RX-API-DMAC7.html)
RU2010107892A (ru) Производные феноксипирролидина, их применение и фармацевтические композиции, содержащие их
JP2017513824A5 (cg-RX-API-DMAC7.html)
JP2009102342A5 (cg-RX-API-DMAC7.html)
MX2024001929A (es) Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de las mismas.
JP2015509075A5 (cg-RX-API-DMAC7.html)
NZ606548A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
BR0309670A (pt) Compostos derivados dicetohidrazina e drogas contendo os compostos como o ingrediente ativo
JP2009532417A5 (cg-RX-API-DMAC7.html)
JP2009513713A5 (cg-RX-API-DMAC7.html)
JP2010509240A5 (cg-RX-API-DMAC7.html)
JP2010505865A5 (cg-RX-API-DMAC7.html)
JP2011046708A5 (cg-RX-API-DMAC7.html)
JP2005526773A5 (cg-RX-API-DMAC7.html)
AR054411A1 (es) Combinacion farmaceutica que comprende un compuesto olefinico de 8- azoniabiciclo [ 3.2.1] octano y uno o mas ingredientes terapeuticos distintos, composicion farmaceutica que la comprende y uso de dichos componentes para prepararla
RU2009128970A (ru) Производные изосорбидмононитрата для лечения кишечных заболеваний
RU2007107935A (ru) Полисульфатированные гликозиды и их соли
WO2009142589A1 (en) Combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist
JP2009532413A5 (cg-RX-API-DMAC7.html)
JP2014530204A5 (cg-RX-API-DMAC7.html)
PE20070828A1 (es) Composicion farmaceutica que contiene una sal de glicopirronio